US 11771748
Methods for treating tumor-induced osteomalacia
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11771748 (Methods for treating tumor-induced osteomalacia) held by Ultragenyx Pharmaceutical Inc. expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ultragenyx Pharmaceutical Inc.
- Grant date
- Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K39/001132